Integra LifeSciences Anticipates Market Recovery in 4Q20

By Mike Evers

Integra LifeSciences Anticipates Market Recovery in 4Q20
The company’s orthopedic business declined in mid-single digits for 1Q20, with a precipitous -80% decline in April. However, Integra expects the market to right itself by year-end.

Member-Only Content

SUBSCRIBE Login

Tags: Revenue Report